Support for RGS4 as a susceptibility gene for schizophrenia

BACKGROUND The gene encoding the regulator of G-protein signaling 4 has recently been associated with susceptibility to schizophrenia. This finding is particularly interesting, because it was replicated within the same study and also because there are functional, positional, and expression data to support the regulator of G-protein signaling 4 as a schizophrenia candidate gene. Although the original report was highly suggestive, a limitation was that the study was conducted on rather small samples. METHODS We have examined a large case (n = 709) control (n = 710) sample for association between schizophrenia using four markers investigated in the earlier study, denoted single nucleotide polymorphisms 1, 4, 7, and 18. RESULTS We were able to replicate the associations with single nucleotide polymorphisms 4 and 18 that had previously been reported individually and have also identified significant association with haplotypes constructed from single nucleotide polymorphisms 1 and 4. CONCLUSIONS Our data give modest support for the hypothesis that the regulator of G-protein signaling 4 is a susceptibility gene for schizophrenia.

[1]  N Risch,et al.  The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. , 1998, Genome research.

[2]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[3]  R. Straub,et al.  Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. , 2002, American journal of human genetics.

[4]  M. Owen,et al.  Association studies in psychiatric genetics , 1997, Molecular Psychiatry.

[5]  Michael C O'Donovan,et al.  A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. , 2003, American journal of human genetics.

[6]  K. Blumer,et al.  Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family , 1996, Nature.

[7]  M C O'Donovan,et al.  Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia , 2003, Molecular Psychiatry.

[8]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[9]  M. Owen,et al.  A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. , 1999, Human molecular genetics.

[10]  Margot Albus,et al.  Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. , 2003, American journal of human genetics.

[11]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[12]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[13]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[14]  Daniel Auerbach,et al.  Identification of novel ErbB3-interacting factors using the split-ubiquitin membrane yeast two-hybrid system. , 2003, Genome research.

[15]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[16]  P. Sham,et al.  Model-Free Analysis and Permutation Tests for Allelic Associations , 1999, Human Heredity.

[17]  M J Owen,et al.  Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). , 2004, Archives of general psychiatry.

[18]  B. Devlin,et al.  Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.

[19]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[20]  J. Leysen,et al.  Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions , 2003, Journal of neurochemistry.

[21]  Kari Stefansson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[22]  M. Owen,et al.  Candidate-gene association studies of schizophrenia. , 1999, American journal of human genetics.

[23]  P. Kwok,et al.  Fluorescence polarization in homogeneous nucleic acid analysis. , 1999, Genome research.

[24]  T. Brugha,et al.  SCAN. Schedules for Clinical Assessment in Neuropsychiatry. , 1990, Archives of general psychiatry.

[25]  N Risch,et al.  The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. II. Individual genotyping. , 1999, Genome research.

[26]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.